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Abstract
Background: Clostridium difficile infections (CDI) are the most frequent cause of diarrhoea in hospitals. Geriatric
patients are more often affected by the condition, by a relapse and complications. Therefore, a crucial question is
how often colonization with toxigenic Clostridium difficile strains occurs in elderly patients without diarrhoea and
whether there is a “risk pattern” of colonized patients that can be defined by geriatric assessment. Furthermore,
the probability for those asymptomatic carriers to develop a symptomatic infection over time has not been
sufficiently explored.
Methods: We performed a cohort study design to assess the association of clinical variables with Clostridium
difficile colonization. The first stool sample of 262 consecutive asymptomatic patients admitted to a geriatric unit
was tested for toxigenic Clostridium difficile using PCR (GeneXpert, Cepheid). A comprehensive geriatric
assessment (CGA) including Barthel Index, Mini Mental State Examination (MMSE) and hand grip-strength was
performed. In addition, Charlson Comorbidity Index, body mass index, number and length of previous hospital
stays, previous treatment with antibiotics, institutionalization, primary diagnoses and medication were recorded
and evaluated as possible risk factors of colonization by means of binary logistic regression. Secondly, we
explored the association of C. difficile colonization with subsequent development of CDI during hospital stay.
Results: At admission, 43 (16.4%) patients tested positive for toxin B by PCR. Seven (16.3%) of these colonized
patients developed clinical CDI during hospital stay, compared to one out of 219 patients with negative or invalid
PCR testing (Odds ratio 12,3; Fisher’s exact test: p = 0.000). Overall, 7 out of 8 (87.5%) CDI patients had been
colonized at admission. Risk factors of colonization with C. difficile were a history of CDI, previous antibiotic
treatment and hospital stays. The parameters of the CGA were not significantly associated with colonization.
Conclusion: Colonization with toxigenic Clostridium difficile strains occurs frequently in asymptomatic patients
admitted to a geriatric unit. Previous CDI, antibiotic exposure and hospital stay, but not clinical variables such as
CGA, are the main factors associated with asymptomatic Clostridium difficile carriage. Colonization is a crucial risk
factor for subsequent development of symptomatic CDI.
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Background
Clostridium difficile infections (CDI) have become the
most frequent cause of diarrhoea in hospitals and care
facilities [1]. Higher age, recent hospitalization, previ-
ous treatment with antibiotics, previous CDI, immuno-
suppression, proton pump inhibitor (PPI) use, surgical
interventions, living in a care facility and known co-
morbidities are all associated with the development of a
CDI [2–6]. Relapses and multiple recurrences consti-
tute an increasing problem [7–10].
CDI patients have a 2.5 times increased 30-day mortal-
ity compared to in-patients without diarrhoea; the CDI-
related mortality is approximately 10% [11]. In geriatric
patients, the severity of the disease course, the recur-
rence rates and the mortality are even higher [12–14].
The pathogen causing the symptomatic CDI may be
present at admission, or it may be acquired during the
hospital stay. Colonization rates for geriatric depart-
ments have not yet been investigated.
Neither has it been conclusively established in which
way asymptomatic carriage influences the risk of a
symptomatic CDI disease nor to what degree it plays a
relevant role in the spreading of the pathogen [15]. Since
geriatric patients are often affected by CDI with a ten-
dency to serious progression and recurrence [16–19], we
examined patients at the moment of admission to a geri-
atric ward for the prevalence of asymptomatic toxigenic
C. difficile carriage including the causal risk factors. We
explored whether a risk pattern for carriage can be de-
fined within the geriatric assessment and how likely it is
for asymptomatic carriers to develop a symptomatic CDI
during their hospital stay.
Methods
The study was designed as a cohort study. Following
approval (PV4643) by the ethics committee of the
Ärztekammer Hamburg (Hamburg’s General Medical
Council), 262 patients without diarrhoea consecutively
admitted to the geriatric unit of the Marienkrankenhaus
from March to November 2014 were examined. The
Katholisches Marienkrankenhaus gGmbH is a teaching
hospital of the University of Hamburg with 550 inpatient
beds in total in various different medical units. The geriat-
ric department consists of 5 wards of 126 beds. Written
consent was obtained after detailed information and ex-
planation of the study procedures.
First, we tried to assess the association of clinical vari-
ables with Clostridium difficile colonization.
Secondly, we explored the association of C. difficile
colonization with subsequent development of CDI. Pa-
tients were monitored throughout their hospital stay
with regard to the development of a symptomatic CDI.
As described in 2.5, Statistical analyses, a required
number of at least 250 patients had been calculated
based on an examined rate of CDI of 4% in geriatric in-
patients in 2012 in the Katholisches Marienkrankenhaus.
Only patients without diarrhoea were included with
diarrhoea being defined as the occurrence of >3 un-
formed stools per day. Participation could be revoked at
any time without stating any reasons. Stool samples at
the first bowel movement after hospital admission were
collected for testing. They were to be delivered within
6 days after admission obtained spontaneously; later
stool samples were not evaluated.
Patients who had acute diarrhoea, or who declined
participation, or who were incapable of giving consent
and had no legal representative, or whose legal represen-
tative refused consent were excluded.
Patients who agreed to take part but failed to deliver a
stool sample within the first 6 days after admission were
excluded as well. The first stool sample of each partici-
pant was tested for toxigenic Clostridium difficile using
PCR (see Lab analysis.).
Data collection
The following anamnestic data of the patients taking
part were recorded: age, sex, date of admission, current
duration of hospital stay, number and duration of previ-
ous hospital stays within the past 6 months, current or
previous treatments with antibiotics within the past
6 months and the respective agents, medication with
proton pump inhibitors (PPI) or immunosuppressants.
In our patients the following immunosuppressant drugs
were used: systemic corticosteroids, methotrexate, ciclos-
porine and leflunomide; two patients had just finished a
cycle of cytostatic medication with R-CHOP (including ri-
tuximab, cyclophosphamide, vincristine, doxorubicine and
prednisolone).
The immediately previous place of residence was cate-
gorized as transfer from 1) a stay at an external hospital,
2) a different department of the same hospital, 3) home,
which also included a care facility. Further, the place of
residence before admission to hospital was recorded: liv-
ing independently, in sheltered accommodation, or
within a care facility; in addition, known previous CDI
episodes (medical history, referral letters) and one fur-
ther category, “post-surgery” (surgery as the initial rea-
son for admission to hospital), were included, assuming
a higher risk of colonization in this patient group.
Geriatric assessment at admission
At the time of admission, all participating patients
underwent the following geriatric assessment: Barthel
Index [20], Mini Mental State Examination (MMSE) [21],
measuring Handgrip Strength in kPa [22], and Timed up
and Go [23]. Additionally, the Body Mass Index was deter-
mined and the presence of comorbidities was recorded
using the Charlson Comorbidity Index [24].
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Lab analysis
In all participating patients, the first stool sample after
admission to the geriatric ward was tested for toxigenic
C. difficile using PCR. A commercially available PCR
test system was used: the Xpert C. difficile test on the
GeneXpert by Cepheid (Germany, Frankfurt).
This test uses real-time PCR to determine the pres-
ence of toxigenic C.difficile strains by means of nucleic
acid detection of gene sequences of the cytotoxin B
(tcdB) and of the binary toxin (cdt), and also the deletion
of the repressor gene tcdC. This deletion leads to an in-
creased toxin production and is characteristic of the
PCR-ribotype 027 (PFGE-type NAP1 and REA-type B1).
The result either confirms or rules out the existence of
toxigenic C.difficile; if a positive result occurs, additional
information is given on whether the pathogenic strain
ribotype 027 (PFGE-type NAP1, REA-type B1) is likely
to be present or not.
The performance data provided by the test manufac-
turer compared with the toxigenic culture result in a
sensitivity of 100% at a specificity of 93% (Xpert C. dif-
ficile; GXCDIFFICILE-CE-10; 300-9291G Rev E, No-
vember 2012).
In patients who subsequently developed clinical symp-
toms of CDI, an EIA test for glutamate dehydrogenase
(GDH) and, if positive, a follow-up toxin A/B EIA test
were performed (C.DIFF CHEK–60 and C. DIFFICILE
TOX A/B II; TECHLAB/ Alere USA).
Surveillance of the occurrence of a symptomatic CDI
For clinical follow-up, Clostridium difficile infection
(CDI) was defined as diarrhoea with loose stools at least
three times in 24 h, elevated C-reactive protein and
blood leukocyte count, and positive results of GDH and
toxin A/B EIA tests as described above.
Occurring diarrhoea was documented throughout the
entire hospital stay. When diarrhoea occurred, the diag-
nostic lab tests mentioned above were carried out to ei-
ther confirm or rule out a CDI.
At discharge the patient file was evaluated and the
marked fact of a CDI during the stay in the geriatric
ward was recorded for the study.
Statistical analysis
The sample size calculation was based on the follow-up
part of the study: Preliminary examinations in 2012
showed that 4% of all in-patients of the geriatric depart-
ment in our hospital suffered from clinical CDI. As this
rate is in accordance with a literature report in a com-
parable institution [25], we based our sample size calcu-
lation on this assumption. In addition, we assumed that
20% of our patients would be colonized carriers at ad-
mission, but asymptomatic [2, 26]. We aimed to detect a
tenfold increase of clinical infection rate in carriers vs.
non-carriers by means of univariate analysis with a
power of 80% at a level of significance (α) of 5%. Based
on these assumptions, sample size calculation yielded a
sample size of 250.
First, a descriptive characterization of the participants
was made. As a next step, clinical variables were com-
pared between the PCR positive and PCR negative
groups by univariate analysis. Statistical significance was
reached for a bilateral p value ≤ 0.05. Clostridium difficile
colonization (PCR positive) was treated as dependent
variable while clinical features, such as previous anti-
biotic treatment and CGA domains, were treated as in-
dependent variables.
In addition, the significant variables of this univariate
analysis were entered into the binary logistic regression
(“backwards: LR” method) in order to predict the PCR
results. As level of significance for variable entry p ≤ 0.05
was used. The level used for the backward method was
p(out) = 0.10, p(in) = 0.05.
The correlation matrix of the significant variables
was calculated and used for variable entry into the
model in order to minimize the risk of overfitting and
multicollinearity.
Thus, only significant variables of the univariate ana-
lysis were chosen for the multivariate analysis. The cal-
culation was carried out by an independent statistician
using SPSS, version 22.0, according to Schendera [27].
Finally, we compared the initially colonized patients
who developed CDI with the initially colonized patients
who did not fall ill during hospital stay by cross tabula-
tion and Fisher’s exact test (two- sided, p = 0.000).
Results
During the investigation period of March to November
2014, 541 patients admitted to the geriatric department
of the Marienkrankenhaus Hamburg were invited to take
part in the C.difficile study. Of these 541 possible partici-
pants, 77 refused and 19 patients were excluded due to
acute diarrhoea. Therefore, 445 patients were potential
participants in the study. Of this group, 183 patients
failed to send in a stool sample within 6 days of admis-
sion. Most of these patients were mobile and forgot to
take a sample, some of them suffered from constipation.
Both groups showed a similar distribution in ADL
(Barthel Index) and cognition (Mini Mental State Exam-
ination). The number of patients participating and ex-
amined using PCR thus amounted to 262 (Fig. 1; 165
women, 97 men).
Most patients (48.5%) had been transferred from
other departments of the Marienkrankenhaus (mainly
internal medicine, orthopaedic surgery or neurology),
29.8% from various departments of other hospitals. The
remaining 21.8% of the patients had been admitted
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from their homes either as elective or as emergency
cases.
In Germany, about 80% of admissions to a geriatric
ward happen post-acute to restore pre-admission func-
tional status. About 20% of patients are admitted direct,
for example from the emergency department or the gen-
eral practitioner. However, the common characteristics of
geriatric patients are multimorbidity and age, usually over
65 years. The usual length of stay is about 2 to 3 weeks.
The characteristics of patients included in the study
are shown in Table 1.
There was no difference in gender distribution among
participants and non-participants; on average, partici-
pants were 1.5 years younger than non-participants.
Fig. 1 Recruitment and Participation
Table 1 Demographics, epidemiological data and clinical characteristics of patients included in the study
Characteristic Minimum Maximum Mean
± Standard deviation
Percentage
Age 59 100 78.8 ± 7.7
Duration of previous hospital stays within past 6 months [days] 0 180 25.3 ± 27.1
Number of previous hospital stays within past 6 months 0 5 1.5 ± 1.1
Duration of current stay in geriatric department [days] 1 48 16.4 ± 6.7
Time of stool sample after admission [days] 0 6 2.5 ± 1.6
Mini Mental State Examin. /30 0 30 25.1 ± 5.1
Barthel Index/100 0 100 50.9 ± 24.1
Timed Up & Go [Sec] 6 58 23.7 ± 10.9
Charlson CM Index 0 12 3.3 ± 2.4
Handgrip Strength [kPa] 8 86 40.5 ± 16.2
BMI 14.1 51.8 25.8 ± 8.0
PPI premedication 64.5%
Antibiotics within past 6 months 66%
Immunosuppression 16%
Previous episodes of CDI 2.7%
“Post-Surgery” hospital stay 26.7%
Place of residence care facility 8.8%
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Of all 262 stool samples tested using PCR, 212 (80.9%)
showed a negative result, 43 (16.4%) showed a positive
result, and 7 (2.7%) tests yielded an invalid result despite
repeated analysis. The stool samples tested “invalid” did
not differ from the valid tested samples in other
respects.
Statistical evaluation of C.difficile carriage is shown in
Table 2.
The univariate analyses showed significant differences
between PCR positive and PCR negative results (p ≤
0.05) with the following variables:
Number and length of hospital stays within the past
6 months, transfer from hospital stay, treatment with an-
tibiotics within the past 6 months, occurrence of previ-
ous episodes of CDI, transfer from care facility, primary
diagnosis postoperative stay, Charlson Comorbidity Index
(Table 2). Therefore C. difficile colonization expressed as a
positive PCR result was treated as dependent variable and
clinical features (characteristics) listed in Table 2 as in-
dependent variables. Length of hospital stay correlated
by R = 0.58 to the variable hospital stays and was there-
fore excluded from the final multivariate model.
The Charlson Comorbidity Index was significantly as-
sociated with a positive CD-PCR (p = 0.044). However,
the increase of probability was small (OR 1.14; 95% CI:
1.002–1.307).
Further evaluated characteristics, especially further pa-
rameters of the geriatric assessment, did not correlate
significantly (p > 0.1) with the PCR result.
Significant characteristics for the prediction of positive
PCR result in the multivariate model were the number
of previous hospital stays, a previous episode of CDI,
taking antibiotics within the past 6 months and the diag-
nosis “post-surgery hospital stay”.







P value (univariate analysis)
(*significant)
Odds ratio (multivariate analysis)
(95% confidence interval)
Age 80.49 ± 8.93 78.54 ± 7.20 0.123
Day of stool sample
(day after admission)
2.58 ± 1.68 2.42 ± 1.64 0.568
Length of stay in days 17.14 ± 8.25 16.29 ± 6.41 0.454
Number hospital stays
past 6 months
2.07 ± 1.22 1.32 ± 1.00 <0.001* 1.6 times per hospital stay (1.1–2.2)
Length hospital stays
past 6 months
39.88 ± 26.43 22.47 ± 26.39 <0.001* a
Mini Mental State Examination 25.19 ± 4.99 25.10 ± 5.06 0.920
Barthel Index 47.38 ± 23.48 50.86 ± 23.95 0.390
Timed Up & Go 27.81 ± 11.57 23,38 ± 10.83 0.084
Charlson CM Index 3.91 ± 2.71 3.12 ± 2.25 0.044* b
Handgrip Strength 36.95 ± 13.68 41.24 ± 16.62 0.123





P value (univariate analysis)
(*significant)
Odds ratio (multivariate analysis)
(95% confidence interval)





P value (univariate analysis)
(*significant)
Odds ratio (multivariate analysis)
(95% confidence interval)
Immunosuppression 14.0%/86.0% 15.6%/84.4% 0.790
Residence care facility 18.6%/81.4% 6.6%/93.4% 0.010* b
Previous treatment with antibiotics
past 6 months
93.0%/7.0% 60.8%/39.2% <0.001* 3.7 times
(1.0–13.9)
Previous episodes of CDI 11.6%/88.4% 0.9%/99.1% <0.001* 12.3 times
(1.9–81.6)
PPI premedication 76.7%/23.3% 62.3%/37.7% 0.071
“Post–Sugery” hospital stay 53.5%/46.5% 21.2%/78.8% <0.001* 3.5 times
(1.4–8.8)
alength of hospital stay correlated by R = 0.58 to the variable “number of hospital stays” and was therefore excluded from the final multivariate model
bnot statistically significant in the multivariate model
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Only in 1 of 43 positive test results did the test system
indicate the presence of pathogenic ribotype 027.
During their hospital stays, 8 out of 262 participants
developed a symptomatic CD infection. Seven of these 8
symptomatic patients had been found colonized at ad-
mission (87.5%). Of the 43 patients who tested positive
at admission, 7 developed a symptomatic CDI (16.3%).
In the 7 initially colonized and over time symptomatic
CDI patients, no significant differences were found with
regard to the initially recorded risk parameters, com-
pared to the 36 patients who were colonized and did not
fall ill in the course of the study. This may be caused by
the small number of CDI cases, so none of the initially
analysed clinical variables reached statistical significance.
The patients were not monitored during their hospital
stay with regard to different clinical characteristics.
Discussion
In this study, approximately one in every six patients ad-
mitted to the geriatric unit without diarrhoea (16.4%) ar-
rived colonized with toxigenic Clostridium difficile
strains. So far, no comparable data have been shown for
patients in geriatric care. The number of asymptomatic
CD-colonized patients ranges from 0.6% in the hospital
[28] up to 51% in care facilities [29]. Rates of
colonization of in-patients were reported as being be-
tween 9.7 and 15% [2, 26, 30–32]. Therefore,
colonization rate of our geriatric patients, 9% of whom
were admitted from nursery homes and were impaired
in their activities of daily living (average Barthel Index
50/100), lies within the expected range.
We identified risk factors for asymptomatic carriage.
Some of them were already known as risk factors for the
development of a symptomatic CDI [33]. Of these, previ-
ously experienced CDI episodes had the highest impact
(OR 12.3; 95% CI: 1.9–81.6), followed by previous treat-
ments with antibiotics (OR 3.7; 95% CI: 1.0–13.9) and
the primary diagnosis “post-surgery” (OR 3.5; 95% CI:
1.4–8.8). Additionally, the number of previous hospital
stays within the past 6 months raised the probability of a
positive CD-PCR by factor 1.6 each (95% CI: 1.1–2.2).
This corresponds to previous studies which also deter-
mined previous episodes of CDI and treatment with an-
tibiotics as the highest risk factors for a toxigenic CD
colonization [34, 35].
There is an established connection between comor-
bidity and the probability of occurrence and the course
of a CDI [5, 17]. Accordingly, we found a small, signifi-
cant correlation of colonization and the Charlson
Comorbidity Index.
Contrary to our expectations, the parameters of the
geriatric assessment did not correlate with CD carriage.
Geriatric patients are characterized by a diminished
ability to perform activities of daily living (ADL),
reduced mobility and strength and often cognitive im-
pairment. Rao et al. have shown that a diminished func-
tional state is connected with the development at least
of serious courses of CDI [19]. Therefore, it comes as a
surprise to us that neither the Barthel Index, nor the
Timed Up and Go Test nor the handgrip strength were
associated with a higher probability of CD carriage.
A correlation has been described between dementia
and the frequency of MRSA colonization [36]. Thus, a
raised probability of CD carriage might have been ex-
pected in patients with diminished cognitive abilities,
quantified by means of Mini Mental State Examination.
Contrary to our expectations, this cannot be confirmed
here, either.
Intestinal microbiome is increasingly being recognized
as an important health factor. Its potential role for
colonization and infection with Clostridum difficile
seems to be of high importance. The intestinal micro-
biome is highly influenced by environmental factors.
This would explain why in our study factors such as the
number and length of hospital stays and the treatment
with antibiotics seem to play the key role for
colonization with Clostridium difficile. The results of the
geriatric assessment do not seem to be associated with
C.difficile colonization. They might be relevant for the
outbreak, course and outcome of a symptomatic CDI.
Asymptomatic carriage at admission was a decisive
risk factor for the development of a symptomatic infec-
tion during the hospital stay. About 87.5% of the pa-
tients (7 of 8) who developed a CDI in the course of
the study arrived for their hospital stay carrying a toxi-
genic C.difficile strain. In view of this, positive screen-
ing for toxigenic C.difficile carriage at admission would
provide a high predictive value for a later development
of a symptomatic CDI, as described in previous studies
[25, 26, 31, 37].
Some studies substantiate financial and health benefits
to be gained by a C.difficile admission screening com-
bined with intensive hygiene interventions/isolation pro-
cedures [38, 39]. Consequently, knowing a patient’s
carrier status at admission can prove vital and, in posi-
tive cases, it would provide various options how to
manage the situation: providing efficient hygiene man-
agement of these patients would stem the spread of
the pathogen, and the number of secondary CDI cases
could be reduced. And additional options would arise
in the direct medical treatment of these colonized pa-
tients with a significantly higher risk for the develop-
ment of a symptomatic CDI. A therapy with antibiotics
and the agents chosen can then be adapted to this risk
situation. Should any cases of diarrhoea occur, how-
ever, fast counter measures would be possible as this
would suggest a high probability of the C.difficile toxin
as its cause.
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A risk adapted screening including high risk patients
with previous episodes of CDI, previous hospitalization
and previous antibiotic treatment could be reasonable in
the light of our results.
There are various methods for testing for C.difficile
[33]. What is important for efficient admission screening
is a fast result. The gold standard of CDI diagnostics –
the stool culture – takes several days to show a result.
Using PCR from stool samples, as in our study, achieves
a timely detection of C.difficile carriers. It has already
been shown that rectal swabs taken at admission and
tested using PCR following a selective broth preamplifi-
cation can be used for even faster diagnostic [34, 40]. A
disadvantage of the PCR screening test, however, is its
relatively high price.
One limitation of our study is the fact that we failed
to obtain a stool sample in many patients who had
already consented to participate (183 of 445). The rea-
son for this was in most cases that the patients or the
nurses forgot to take a stool sample. The distribution of
Barthel Index and Mini Mental State Examination in
both groups was comparable.
A second limitation is that patients in geriatric wards
are a heterogeneous population. About 80% were trans-
ferred from other departments for further rehabilitation
whereas only about 20% were admitted direct. However,
this is a real-life scenario.
The third limitation is that we were only able to moni-
tor the patients for the time they spent in hospital.
Therefore, conclusions about the development of a CDI
have to be drawn with caution. Colonization seemed to
be a clear risk factor for the development of a CDI. To
what extent the risk factors identified for colonization
also play a role as risk factors for infection cannot be
evaluated due to limited statistical power.
As a further limitation, the sample size calculation of
250 patients was based on an assumed CD carrier rate
at admission of 20% and an in-house CDI rate of 4% for
geriatric patients. The CD prevalence at admission in
our study reached only 16.4% and the infection rate 3.1%
(8 of 262 patients).
Our study is the first to show a high rate of
colonization in geriatric in-patients. With CDI rates and
recurrences on the increase in this population [41, 42],
the usefulness of a PCR screening in a geriatric risk
population should be evaluated in a prospective trial.
Conclusions
This is the first study to show the rate of asymptomatic
carriers in a geriatric unit (16.4%), which lies between
the previously shown rates of other hospital units and
those of care facilities. The parameters of geriatric as-
sessment do not offer any option to predict carriage.
This study, too, finds that the highest risk factors are
previous episodes of CDI, previous treatment with anti-
biotics, and previous hospital stays.
Carriage at admission is a huge risk factor for the de-
velopment of a symptomatic CD infection during the
hospital stay. One in every 6 colonized patients (16.3%)
falls ill during the stay, or in other words, the majority
of patients developing CDI during their stay has arrived
colonized for admission (87.5%). This underlines the
possible importance of screening for carriage in geriatric
units, especially in high-risk patients.
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